These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 34547092)
1. Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies. Slomski A JAMA; 2021 Sep; 326(9):800. PubMed ID: 34547092 [No Abstract] [Full Text] [Related]
2. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination. Abbasi J JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836 [No Abstract] [Full Text] [Related]
3. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection. Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796 [No Abstract] [Full Text] [Related]
4. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity. Abbasi J JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883 [No Abstract] [Full Text] [Related]
14. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation. Jeong H; Choi YM; Seo H; Kim BJ Front Immunol; 2021; 12():637654. PubMed ID: 33732258 [TBL] [Abstract][Full Text] [Related]
15. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724 [TBL] [Abstract][Full Text] [Related]
16. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700 [No Abstract] [Full Text] [Related]
17. Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant. Yi SG; Eagar T; Moore L; Huang HJ; Ibrahim H; Hobeika MJ; McMillan R; Podder H; Ghobrial RM; Gaber AO; Knight RJ Transplantation; 2021 Oct; 105(10):e133-e134. PubMed ID: 34155187 [No Abstract] [Full Text] [Related]
18. Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines. Rubin R JAMA; 2021 Nov; 326(17):1661-1663. PubMed ID: 34647956 [No Abstract] [Full Text] [Related]
19. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572 [No Abstract] [Full Text] [Related]
20. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants. Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487 [No Abstract] [Full Text] [Related] [Next] [New Search]